Regeneron Pharmaceuticals: Summary

Regeneron Pharmaceuticals

Pharmaceuticals, biotechnology, biopharmaceuticals, life sciences

Regeneron transforms cutting-edge science into transformative medicine, aiming to redefine excellence and efficiency in research and development.

Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines. The company harmonizes biology and technology to create life-changing medicines for serious diseases.

Innovative medicines for serious diseases; Integration of biology and technology; Support for STEM education and talent; Commitment to corporate responsibility

The service is most valuable in scenarios involving the treatment of serious diseases, participation in clinical trials, and educational initiatives in STEM.

Strong pipeline of biologics and genetic medicines; Proven track record of scientific breakthroughs; Commitment to ethical practices and community impact

Regeneron is recognized for its innovative approach to medicine, strong research capabilities, and dedication to improving health outcomes through responsible business practices.

Regeneron positions itself as a leader in biopharmaceutical innovation, focusing on the intersection of science and medicine.

The target users include patients with serious diseases, healthcare professionals, and students interested in STEM careers.

Join our team

• biologics

• genetic medicines

• STEM education

• clinical trials

Science to Medicine

Innovative, compassionate, responsible

Regeneron uniquely combines advanced scientific research with a strong commitment to social responsibility and education, particularly in STEM fields.

The brand identity emphasizes scientific excellence, innovation, and a commitment to making a positive impact on society.

1988-01-01

• Eric Shooter

• George D. Yancopoulos

• Leonard S. Schleifer